Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodi Envi vs LillyDirect Foundayo

Bodi Envi
Graded #88

Higher grade

vs+4.599999999999994
LillyDirect Foundayo
Graded #165

Lower grade

The verdict

Bodi Envi takes it — 71.8/100 to 67.2/100.

Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodi Envi +1
73
72
Dose & formulationBodi Envi +13
72
59
Clinical oversightBodi Envi +4
82
78
Labs & monitoringBodi Envi +12
64
52
FulfillmentLillyDirect Foundayo +11
69
80
Contract termsBodi Envi +6
61
55
Bodi Envi · left barLillyDirect Foundayo · right bar

The numbers

MetricBodi EnviLillyDirect Foundayo
WeighScore71.8/10067.2/100
GradeCC
Scorecard rank#88#165
Semaglutide$179/moNot disclosed
Tirzepatide$249/moNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Bodi Envi

Graded #88 · C

Strengths

  • Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
  • No consultation or membership fees
  • Free 2-day shipping included; FSA and HSA eligible
  • 24/7 secure provider messaging with same-day visits and prescriptions
  • Personalized dose titration with side-effect management (Zofran available)

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No insurance billing — cash-pay only
  • States served are not explicitly listed (features vary by state)
  • No LegitScript certification visible on the site
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard